Moscow Deputy Mayor Anastasia Rakova, in a recent interview, highlighted the remarkable success of a program offering free reproductive health screenings to women aged 18 to 40. This initiative notably includes testing for Anti-Müllerian Hormone (AMH), a key indicator of ovarian reserve. Over the past year, an impressive 270,000 women in Moscow have utilized this service, providing authorities with invaluable and previously unavailable population-wide data.
The AMH test measures a woman`s egg supply, with higher levels indicating a larger ovarian reserve and, consequently, better prospects for successful conception and pregnancy. Rakova emphasized that the collected data has revealed significant trends worth noting: «Among women aged 24-29 who underwent the test, 10% already exhibited a reduced ovarian reserve. This indicates a high probability of facing difficulties with family planning in the future, thus underscoring the critical need to address these issues immediately, rather than postponing for even two or three years.» She further revealed that this percentage rises to 20% for women aged 29-34 and an alarming 40% for those aged 35-39.
According to Rakova, a positive outcome of the program is that many women, upon discovering less-than-optimal AMH results, become more proactive and decisive in their family planning efforts. «More than 8,000 women are now on their way to becoming mothers. This represents a significant positive psychological impact of the program,» she concluded.
The free AMH testing program in Moscow officially launched in September 2024. It is accessible to women aged 25 to 39 who possess a Moscow compulsory medical insurance (OMS) policy. For younger women, specifically those aged 18-24, testing is available under certain qualifying conditions, such as having undergone ovarian surgery.
